Related Experiment Videos
[Intratympanic dexamethasone for sudden sensorineural hearing loss]
Yongde Lu1, Jihao Ren, Weijing Wu
1Department of Otolaryngology, Second Hospital of Xiangya Medical College, Central South University, Changsha 410011, China. yongdl2000@yahoo.com.cn
Lin Chuang Er Bi Yan Hou Ke Za Zhi = Journal of Clinical Otorhinolaryngology
|March 22, 2006
Summary
Intratympanic dexamethasone (ITD) effectively treated sudden sensorineural hearing loss (SSNHL), significantly improving hearing by over 40 dB in both ears for a bilateral case.
Area of Science:
- Otolaryngology
- Neurology
- Pharmacology
Background:
- Sudden sensorineural hearing loss (SSNHL) is an otologic emergency requiring prompt treatment.
- Intratympanic dexamethasone (ITD) is a potential therapeutic option for SSNHL.
Observation:
- A case of bilateral SSNHL was treated with intratympanic dexamethasone (ITD).
- Literature review on ITD for SSNHL was conducted.
Findings:
- The patient experienced a hearing improvement exceeding 40 dB in both ears following ITD treatment.
- ITD demonstrated significant efficacy in this SSNHL case.
Implications:
- Intratympanic dexamethasone (ITD) is a viable and effective treatment for sudden sensorineural hearing loss (SSNHL).
- Further research into ITD's role in SSNHL management is warranted.